Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme [Epub ahead of print]

Hézode C, Lebray P, de Ledinghen V, Zoulim F, Di Martino V, Boyer N, et al.. Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme [Epub ahead of print]. Liver international : official journal of the International Association for the Study of the Liver. 2017;.
Top